» Articles » PMID: 15553217

The Arthrotropism of Macromolecules in Adjuvant-induced Arthritis Rat Model: a Preliminary Study

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2004 Nov 24
PMID 15553217
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To study the accumulation of macromolecules into the arthritic joints and the possible applications of such phenomenon.

Methods: The accumulation of plasma albumin in the joints of adjuvant-induced arthritis (AIA) rat model was first visualized with Evans blue injection. A N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer contrast agent was then synthesized and injected into the AIA rats to allow qualitative examination of biodistribution and pharmacokinetics of the injected macromolecule with magnetic resonance imaging (MRI). Vital organs and the diseased joints were isolated and examined histologically to correlate with the MRI findings.

Results: Deep blue color developed around the arthritic joints of the AIA rat a few hours after the injection of Evans blue. MR imaging of the AIA rats injected with polymer contrast agent demonstrated a gradual but very strong accumulation of the injected polymer in the arthritic joints, which lasted for 1-2 days. Observed differences in the concentration of the injected polymer in the joints correlated with disease severity as assessed histologically.

Conclusions: Profound arthrotropism of macromolecules in the AIA rat model was demonstrated with various imaging tools. These observations should help in the conceptual and practical design of novel macromolecular delivery systems for the imaging and treatment of rheumatoid arthritis.

Citing Articles

Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases.

Deng Z, Liu S Drug Deliv Transl Res. 2021; 11(4):1475-1497.

PMID: 33860447 PMC: 8048351. DOI: 10.1007/s13346-021-00977-8.


Polymer nanomedicines.

Kopecek J, Yang J Adv Drug Deliv Rev. 2020; 156:40-64.

PMID: 32735811 PMC: 7736172. DOI: 10.1016/j.addr.2020.07.020.


Extended blood circulation and joint accumulation of a p(HPMA-co-AzMA)-based nanoconjugate in a murine model of rheumatoid arthritis.

Ebbesen M, Bienk K, Deleuran B, Howard K Mol Cell Ther. 2015; 2:29.

PMID: 26056596 PMC: 4452064.


Macromolecular therapeutics.

Yang J, Kopecek J J Control Release. 2014; 190:288-303.

PMID: 24747162 PMC: 4142088. DOI: 10.1016/j.jconrel.2014.04.013.


Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes.

Quan L, Zhang Y, Crielaard B, Dusad A, Lele S, Rijcken C ACS Nano. 2013; 8(1):458-466.

PMID: 24341611 PMC: 3947749. DOI: 10.1021/nn4048205.